Search - tctmd.com

Displaying 261 - 280 of 391

Sort: Relevancy | Date

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

News Daily News

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

L.A. McKeown

February 26, 2015

News Daily News

TRYTON Published: Noninferiority Not Shown for Dedicated Bifurcation Stent

Yael L. Maxwell

February 19, 2015

Presentation BRS 2015

BIORESORBABLE VASCULAR SCAFFOLDS A One-day Case-based Technique-oriented Course: A Case with Vessel and - or Lesion Tortuosity

Presenter: Antonio L. Bartorelli

February 10, 2015

Presentation

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Presenter: J. W?hrle

December 21, 2014

News Daily News

ASSURE Registry: Angiographic, Clinical Outcomes of BRS Similar to DES at 1 Year

L.A. McKeown

December 21, 2014

News Daily News

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

December 04, 2014

News Daily News

对STEMI使用生物可吸收支架的立即、中期结果令人鼓舞

Todd Neale

November 17, 2014

News Daily News

Los Resultados Inmediatos y a Medio Plazo son Esperanzadores para los Andamiajes Bioabsorbibles en el Manejo de STEMI

Todd Neale

November 17, 2014

News Daily News

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

Todd Neale

November 17, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

Presentation TCT 2014

Con: The Psychological Attraction Will Pass When the Data Emerges!

Presenter: Daniel I. Simon

September 16, 2014

Presentation TCT 2014

Pro: Within 10 Years, Most Coronary Intervention Will Use BRS!

Presenter: Stephan Achenbach

September 16, 2014

Presentation TCT 2014

TCT 612: Clinical Outcomes in Patients with Calcified Lesions Treated with Bioresorbable Vascular Scaffolds

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Vasileios Panoulas

September 16, 2014

Presentation TCT 2014

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Juan F. Granada

September 16, 2014

Presentation TCT 2014

TCT 611: Multimodality Assessment 12 Months After Implantation of a Bioresorbable Scaffold for the Treatment of Culprit Lesions in Myocardial Infarction

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Ulrich Hink

September 16, 2014

Presentation TCT 2014

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Laura Mauri

September 16, 2014

Presentation TCT 2014

Imaging to Guide BRS: Nice to Have or Must Have?

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Evelyn S. Regar

September 16, 2014

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Tips, Tricks, and Pearls to Optimize BRS Outcomes: From Lesion Preparation to Pharmacotherapy Considerations

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Jonathan M. Hill

September 16, 2014

Advertisement

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

TRYTON Published: Noninferiority Not Shown for Dedicated Bifurcation Stent

BIORESORBABLE VASCULAR SCAFFOLDS A One-day Case-based Technique-oriented Course: A Case with Vessel and - or Lesion Tortuosity

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

ASSURE Registry: Angiographic, Clinical Outcomes of BRS Similar to DES at 1 Year

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

对STEMI使用生物可吸收支架的立即、中期结果令人鼓舞

Los Resultados Inmediatos y a Medio Plazo son Esperanzadores para los Andamiajes Bioabsorbibles en el Manejo de STEMI

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

Con: The Psychological Attraction Will Pass When the Data Emerges!

Pro: Within 10 Years, Most Coronary Intervention Will Use BRS!

TCT 612: Clinical Outcomes in Patients with Calcified Lesions Treated with Bioresorbable Vascular Scaffolds

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

TCT 611: Multimodality Assessment 12 Months After Implantation of a Bioresorbable Scaffold for the Treatment of Culprit Lesions in Myocardial Infarction

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Imaging to Guide BRS: Nice to Have or Must Have?

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Tips, Tricks, and Pearls to Optimize BRS Outcomes: From Lesion Preparation to Pharmacotherapy Considerations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content